1-甲基-3-氧代-2-苯基哌嗪 | 5368-20-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 中文名称: 1-甲基-3-氧代-2-苯基哌嗪
• 中文别名: 4-甲基-3-苯基哌嗪-2-酮
• 英文名称: 4-methyl-3-phenylpiperazin-2-one
• 英文别名: 3-Phenyl-4-methyl-2-piperazinon
• CAS: 5368-20-7
• 化学式: C₁₁H₁₄N₂O
• 分子量: 190.245
• InChiKey: KUVJOLVZDVEQGN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933599090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  3-氧代-2-苯基哌嗪	3-phenylpiperazin-2-one	5368-28-5	C10H12N2O	176.218

反应信息

• 作为反应物：
  描述：

  4-(5-chloro-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)morpholine 、 1-甲基-3-氧代-2-苯基哌嗪 在 tris-(dibenzylideneacetone)dipalladium(0) 、 caesium carbonate 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下， 以 二甲基亚砜 为溶剂， 以6.7 %的产率得到4-methyl-1-(7-morpholino-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-5-yl)-3-phenylpiperazin-2-one
  参考文献：
  名称：

  [EN] COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE
  [FR] COMPOSÉS ET COMPOSITIONS QUI INHIBENT PIKFYVE

  摘要：

  Pyrazolo[1,5-a]pyrimidines are disclosed. These compounds may be useful in the treatment of neurological disorder, including frontotemporal dementia, chronic traumatic encephalopathy, Alzheimer's disease, limbic-predominant age-related TDP-43 encephalopathy, or frontotemporal lobar degeneration. Further, the invention features a method of inhibiting toxicity in a cell related to a protein TDP-43 or C9orf72. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

  公开号：

  WO2023107557A1
• 作为产物：
  描述：

  3-氧代-2-苯基哌嗪 、 碘甲烷 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 以57 %的产率得到1-甲基-3-氧代-2-苯基哌嗪
  参考文献：
  名称：

  [EN] COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE
  [FR] COMPOSÉS ET COMPOSITIONS QUI INHIBENT PIKFYVE

  摘要：

  Pyrazolo[1,5-a]pyrimidines are disclosed. These compounds may be useful in the treatment of neurological disorder, including frontotemporal dementia, chronic traumatic encephalopathy, Alzheimer's disease, limbic-predominant age-related TDP-43 encephalopathy, or frontotemporal lobar degeneration. Further, the invention features a method of inhibiting toxicity in a cell related to a protein TDP-43 or C9orf72. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

  公开号：

  WO2023107557A1

文献信息

• [EN] COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE<br/>[FR] COMPOSÉS ET COMPOSITIONS QUI INHIBENT PIKFYVE
  申请人：[en]KINETA, INC.

  公开号：WO2023107557A1

  公开（公告）日：2023-06-15

  Pyrazolo[1,5-a]pyrimidines are disclosed. These compounds may be useful in the treatment of neurological disorder, including frontotemporal dementia, chronic traumatic encephalopathy, Alzheimer's disease, limbic-predominant age-related TDP-43 encephalopathy, or frontotemporal lobar degeneration. Further, the invention features a method of inhibiting toxicity in a cell related to a protein TDP-43 or C9orf72. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.